Pyxis Oncology, Inc. (PYXS)

CIK 1782223 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pyxis Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 20268-K0001193125-26-385901
Sep 8, 202640001193125-26-384391
Sep 8, 20268-K0001193125-26-384386
Aug 28, 2026424B20001193125-26-372221
Aug 27, 2026EFFECT9999999995-26-002786
Aug 20, 202640001193125-26-359525
Aug 20, 2026S-30001193125-26-359246
Aug 14, 202640001193125-26-352206
Aug 13, 20268-K0001193125-26-347911
Aug 13, 202610-Q0001193125-26-347913
Jul 10, 2026SCHEDULE 13G0000921895-26-001796
Jul 10, 202630000919574-26-004386
Jul 2, 2026SCHEDULE 13G/A0000919574-26-004255
Jul 2, 20268-K0001193125-26-294613
Jul 2, 202640001193125-26-294708
Jun 30, 20261440001959173-26-004977
Jun 15, 20268-K0001193125-26-271137
May 14, 20268-K0001193125-26-222818
May 14, 202610-Q0001193125-26-222843
Apr 30, 2026DEF 14A0001193125-26-194032
Apr 30, 20268-K/A0001193125-26-193940
Apr 30, 2026ARS0001193125-26-194065
Apr 30, 2026DEFA14A0001193125-26-194051
Mar 25, 202640001193125-26-124348
Mar 25, 202640001193125-26-124333